CPC Subgroup
A61K 31/4738 ortho- or peri-condensed with heterocyclic ring systems
Full Title
Medicinal preparations containing organic active ingredients > Heterocyclic compounds > having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins > having six-membered rings with one nitrogen as the only ring hetero atom > Quinolines; Isoquinolines > ortho- or peri-condensed with heterocyclic ring systems
3 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 31/4741 condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
- A61K 31/4743 condensed with ring systems having sulfur as a ring hetero atom
- A61K 31/4745 condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines (yohimbine derivatives, vinblastine A61K31/475; ergoline derivatives A61K31/48)
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513